During the current pandemic, we have diverted resources and expertise into developing simple, low cost and scalable testing products for Sars-CoV-2.
These products are available for testing laboratories wishing to implement extraction and qRT-PCR protocols in their own labs or through our service facility.
Nonacus now offers the following:
- Fully supported workflow for nasopharyngeal swabs and other biofluids: A low cost and fast extraction process using a simple bead based protocol that allows rapid purification of viral RNA from swab samples and other biofluids
- Sensitive single and multiplex qRT-PCR assays for Sars-CoV-2: Validated for nasopharangeal swabs and other biofluids
- Service facility with capacity to process 2000 extractions per day: Highly automated processing ensures results are delivered quickly and efficiently.
VirPath – Bead Xtract Viral DNA/RNA Extraction kit:
This extraction kit is designed for the rapid and reliable isolation of viral DNA or RNA from nasopharyngeal swabs or other biofluids. The magnetic bead-based technology enables the purification of high-quality ribonucleic acid free from protein and other impurities required for downstream qRT-PCR. Fast, low cost and easily scaled up or down, the VirPath - Bead Xtract Viral DNA/RNA kit is ideally suited to Sars-CoV-2 testing.
VirPath - Sars-CoV-2 qRT-PCR kits:
Nonacus have developed both single and multiplex, one step qRT-PCR kits using proven primer and probe sequences targeting Sars-CoV-2.
VirPath - Sars-CoV-2 Single-Plex qRT-PCR kit:
This is a single-plex test which covers N1, N2 and RP assays defined by the US Centre for Disease Control (CDC) which have been extensively validated for the detection of Sars-CoV-2. The kit is suitable for customers with 1 or 2 colour systems and is provided with both positive and negative controls.
VirPath - Sars-CoV-2 Multiplex qRT-PCR kit:
This multiplex kit uses a combination of the best performing proven CDC and WHO assays and targets the nucleocapsid gene (assay N1), the envelope gene (assay E) of Sars-CoV-2 and the RPP30 gene (assay RP) used as an internal RNA extraction control. The kit is suitable for customers with 3, 4 or 5 colour systems and is provided with both positive and negative controls.
Saliva test could help meet Boris Johnson's 24-hour target - 6 June 2020
The Government is in talks with a British firm about rolling out a saliva test for coronavirus.
UK firm develops coronavirus spit test which could be done at home - 11 April 2020
A partnership between Nonacus Ltd and Chronomics has led to the development of a spit test for COVID-19
|VirPath - Sars-CoV-2 qRT-PCR kit, 1,000 reactions||C3COV191|
|VirPath - Sars-CoV-2 qRT-PCR kit, 10,000 reactions||C3COV192|
|VirPath – Bead Xtract Viral DNA/RNA Extraction, 1,000 samples||C3COV193|
|VirPath – Bead Xtract Viral DNA/RNA Extraction kit, 10,000 samples||C3COV194|